UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in CRL — Charles River Laboratories International, Inc.
CIK 861177
NEW YORK, NY
Position in CRL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$37,762,491
-$3,915,260 QoQ
Shares Held
218,913
+4.8% QoQ
Ownership
0.454%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 62.0296647526643.ToString("F0")%
Shared 0.ToString("F0")%
None 37.970335247335704.ToString("F0")%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,972,110,878 across 32 Diagnostics & Research names. CRL ranks #16 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,449,697 | $1,204,099,562 | |
| 2 | DHR |
Danaher Corp /De/
|
5,225,861 | $990,823,242 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
871,789 | $489,849,516 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
241,360 | $304,403,227 | |
| 5 | A |
Agilent Technologies, Inc.
|
2,646,458 | $301,643,277 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
1,499,267 | $255,684,990 | |
| 7 | LH |
Labcorp Holdings Inc.
|
900,202 | $240,182,890 | |
| 8 | WAT |
Waters Corp /De/
|
794,589 | $236,628,599 |
All Filings in CRL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,762,491 | 218,913 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $41,677,751 | 208,932 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $32,584,354 | 208,260 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $43,049,893 | 283,727 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $37,122,441 | 246,628 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $55,056,946 | 298,250 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $49,489,888 | 251,256 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $54,797,199 | 265,259 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $59,794,867 | 220,686 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $51,994,758 | 219,944 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $31,472,619 | 160,591 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $30,597,469 | 145,529 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $29,370,658 | 145,529 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $28,035,880 | 128,664 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $25,421,045 | 129,172 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $29,119,813 | 136,093 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $39,551,053 | 139,279 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $53,820,757 | 142,844 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $57,363,189 | 139,005 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $48,397,738 | 130,833 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $23,539,118 | 81,217 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $22,911,158 | 91,696 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $18,213,370 | 80,430 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $27,334,763 | 156,781 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $17,058,664 | 135,161 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||